# Efficacy and Safety of Simvastatin-ezetimibe Combination Therapy Among Patients With SLE

> **NCT02548936** · EARLY_PHASE1 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 30 (actual)

## Conditions studied

- Atherosclerosis

## Interventions

- **DRUG:** Ezetimibe+Simvastatin Drug Combination

## Key facts

- **NCT ID:** NCT02548936
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-04
- **Primary completion:** 2016-10
- **Final completion:** 2016-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2015-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02548936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02548936, "Efficacy and Safety of Simvastatin-ezetimibe Combination Therapy Among Patients With SLE". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02548936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*